Collaboration in biotech projects
הזדמנות עסקית זאת היא בת למעלה מחצי שנה
מומלץ לבדוק האם היא עדיין בתוקף
We are a Danish, not-for-profit, RandD-based company owned by the Technical University of Denmark and specialized in early validation of pharmaceutical candidates, formulation development- and characterization and recombinant protein production. The company is an approved technological service partner (accreditation from the Danish government), and thereby committed to develop advanced technologies for the Danish and international biotech industry. Early validation studies are carried out through human disease models based on iPSC (stem cell reprogramming) technology, immune pathway models (DC and T-cell) and biomarker- and histological analysis. In the preclinical stage, the company offers compound- and formulation characterization and development, including ADME properties (small molecules and biologics). Additionally, the company possess a unique advanced dynamic gut model, which allows the prediction of bio-performance in a physiological in-vitro model. Finally, we have vast experience with production of recombinant proteins in advanced microbial- and mammalian strains and can offer strain development and optimization along with upstream- and downstream process development. We are serving a large portion of Danish (and international) biotech companies in discovery-and preclinical phases. Furthermore, we collaborate internationally in the framework of the EU and Eurostars programme. We welcome discussions with companies, universities and hospitals on potential projects and collaboration opportunities.